Isolating Dermal Stem Cells via Enzyme Treatment and Suspension Culture

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current sources for mesenchymal stem cells, such as bone marrow and cord blood, are limited, and there is no established method for isolating these cells from dermal tissue, which could provide a more abundant and ethically favorable source for regenerative and cosmetic medicine.

Innovation Solution

A method involving enzyme treatment of skin tissue followed by suspension culture to restore stem cell marker expression and isolate CD34-positive, potentially NG2-positive dermal stem cells, which are then differentiated into various cell types like adipocytes, osteocytes, and chondrocytes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If mesenchymal stem cells are isolated from bone marrow, then stem cells can be obtained for regenerative medicine, but the source is limited and productivity is low

Engineering Contradiction:
Improveavailability of stem cellsVSAvoidisolation efficiency
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The invention extracts mesenchymal stem cells from dermal tissue instead of bone marrow, utilizing a different biological source that is more accessible and abundant. The method involves isolating stem cells from the dermis layer of skin tissue, which can be obtained through less invasive procedures compared to bone marrow extraction, thereby increasing both availability and productivity of stem cell sources.

Inventive Principle:
Principle #2Taking out (Extraction)

2Ease of manufacture

If enzyme treatment is applied to skin tissue, then cells can be separated from tissue, but stem cell marker expression decreases

Engineering Contradiction:
Improvecell separation efficiencyVSAvoidstem cell marker expression
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The invention applies preliminary suspension culture treatment to the enzyme-digested cells before isolation. This preliminary action allows the cells to recover and restore stem cell marker expression that was reduced during the enzyme treatment process, ensuring that the cells maintain their stem cell characteristics while still achieving effective separation from the tissue.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention changes the cultural parameters from adherent culture to suspension culture after enzyme treatment. This parameter change enables the cells to recover their stem cell marker expression levels while maintaining the benefits of enzyme-based tissue separation, effectively resolving the contradiction between ease of separation and reliability of marker expression.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If adhesion culture is used for enzyme-treated cells, then cells can be cultured, but stem cell marker expression remains low and differentiation ability is reduced

Engineering Contradiction:
Improvecell culture efficiencyVSAvoidstem cell marker expression
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention inverts the conventional approach by using suspension culture instead of adhesion culture for the initial cell expansion phase. This inversion allows enzyme-treated cells to recover their stem cell marker expression and maintain differentiation ability, while still achieving efficient cell culture. The cells are then transferred to adhesion culture for long-term maintenance, combining the benefits of both approaches.

Inventive Principle:
Principle #13The other way round (Inversion)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for the efficient isolation and high differentiation ability of dermal stem cells, providing a promising source for regenerative medicine and contributing to the understanding of skin homeostasis and aging.

Implementation Method 1

skin tissue was separated with enzyme

Methodology Applied
Scientific EffectEnzyme: Enzyme

Implementation Method 2

subjecting cells separated from the skin by enzyme treatment to suspension culture

Methodology Applied
Scientific EffectSuspension: Suspension

Data Source

PatentUS8962323B2Method of isolating dermal stem cells
Publication Date: 2015.02.24 SHISEIDO CO LTD
  • US8962323B2 patent drawing
  • US8962323B2 patent drawing
  • US8962323B2 patent drawing

AI summary

The invention provides a method of isolating dermal stem cells, having the steps of subjecting cells separated from the skin by enzyme treatment to suspension culture, and isolating cells positive for stem cell markers from the cultured cells.